Overview
Math Leers practices in Heerlen, Netherlands. Leers is rated as an Advanced expert by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Their top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Erysipelas.
Their clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Acute Myeloblastic Leukemia without Maturation.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Experienced
- Acute Coronary SyndromeLeers isExperienced. Learn about Acute Coronary Syndrome.
- Acute Myeloid Leukemia (AML)Leers isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnginaLeers isExperienced. Learn about Angina.
- COVID-19Leers isExperienced. Learn about COVID-19.
- ErysipelasLeers isExperienced. Learn about Erysipelas.
- LeukemiaLeers isExperienced. Learn about Leukemia.